Study answers Medicare concerns about paying for CT colonography

July 1, 2012

A new study of 1,400 Medicare-aged patients reinforces CT colonography as a screening tool for colon cancer, adding to the continued debate over Medicare coverage of the procedure.

In 2009, the Centers for Medicare and Medicaid Services indicated that CT colonography would not be covered, in part, because outcomes data specific to the Medicare population was not available.

"Our study answers several of the questions Medicare asked about this procedure," said Brooks Cash, MD, one of the authors of the study. The study found that the percentage of patients that would have been referred to as a result of CT colonography was 14%, which is similar to what other studies have found in the younger population, said Dr. Cash. "The prevalence of neoplasia (abnormal growths of cells) detected by CT colonography was 9.3% in patients over the age of 65," which is also similar to the results of other studies involving younger patients," he said.

Potentially important extracolonic findings were identified in 2.9% of the study group. "The confirmation of low rates of referral to colonoscopy, the prevalence of advanced neoplasia and the prevalence of extracolonic findings makes CT colonography a viable option for Medicare-aged patients," said Dr. Cash.

The Centers for Medicare and Medicaid Services had also expressed concern about the of colonoscopy, said Dr. Cash. "The average effective radiation dose with CT colonography at the National Naval Medical Center in Bethesda, MD (where the study was conducted) was calculated to be 4.24 mSv per CT colonography examination. To put that in perspective, the average yearly of American adults is about 6.2mSv," Dr. Cash said.

Several previous studies have shown that up to 40% of individuals undergoing CT colonography say they would not have been screened for if CT colonography had not been available to them. "This is the real value of CT colonography – offering an alternative, high quality, total colonic preventative screening to a large percentage of the population that either refuses or is unable to undergo colonoscopy," said Dr. Cash.

Currently about 50-60% of patients eligible for colon cancer screening undergo any kind of screening examination; "we have calculated in our practice that we could increase screening compliance rates by about 15% if was covered by Medicare or third party payers," Dr. Cash said.

The study appears in the July, 2012 American Journal of Roentgenology, published by the American Roentgen Ray Society.

Explore further: CT colonography shown to be comparable to standard colonoscopy

Related Stories

CT colonography shown to be comparable to standard colonoscopy

February 23, 2012
Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older, according ...

Colon Cancer Alliance and American College of Radiology demand Medicare cover virtual colonoscopy

February 23, 2012
In response to a study published online Feb. 23 in Radiology which showed that virtual colonoscopies are comparably affective to standard colonoscopy at detecting colorectal cancer and precancerous polyps in adults ages 65 ...

Study: Virtual colonoscopy effective screening tool for adults over 65

February 23, 2012
Computed tomography (CT) colonography can be used as a primary screening tool for colorectal cancer in adults over the age of 65, according to a new study published online in the journal Radiology.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.